Navigation Links
Organovo Rings Opening Bell On New York Stock Exchange
Date:7/15/2013

NEW YORK, July 15, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE: ONVO), today rang the opening bell on the New York Stock Exchange (NYSE).  Organovo Holdings, Inc. shares began trading on the NYSE on Thursday, July 11, 2013, after qualifying as an NYSE MKT listing company.

"Organovo is proud to ring the opening bell on behalf of our employees, investors and all of our supporters, in recognition of our recent uplisting to the New York Stock Exchange.  This milestone is another important step forward for the company in our mission to advance the impact of 3D bioprinting in changing the shape of medical research and practice," said Keith Murphy, president and chief executive officer of Organovo Holdings, Inc.  "We found NYSE to have made an unparalleled commitment to providing a fertile platform for growth to early stage biotechnology companies, and we look forward to a great future on the exchange."

"As Scientific Founder of Organovo I am deeply moved by this latest success of the company," said Professor Gabor Forgacs of the University of Missouri-Columbia and Clarkson University.  "For a scientist, watching the progress of one's technology represents the ultimate dream come true, and it is rewarding to see the numerous nights spent in the academic lab, combined with the many long hours devoted by Organovo's team, creating realistic hope for many patients for improved quality of life."

The uplisting allows Organovo investors to utilize the trading, connectivity and routing technologies of the NYSE platform and offers superior price discovery, superior liquidity and reduced trading volatility.  Listed companies benefit from issuer-selected Designated Market Makers (DMM) that utilize world-class NYSE trading systems to discover and improve prices, dampen v
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
2. Organovo To List Common Stock On New York Stock Exchange MKT
3. Organovo Appoints Tamar D. Howson to Board of Directors
4. Organovo to Present at the 12th Annual Needham Healthcare Conference
5. Organovo Partners With ZenBio to Create 3D Tissue Models
6. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. Organovo Reports Q3 2012 Financial Results, Provides Business Update
8. Organovo To Present At Lazard Healthcare Conference
9. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
10. Organovo Announces Relocation and Commencement of Operations at Larger Facility
11. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015  Axovant Sciences Ltd. (NYSE:  AXON), a ... of dementia, today announced that the company will ... 5:45 p.m. EDT following its presentation of RVT-101 ... 2015 (AAIC). The event will ... Lawrence Friedhoff , Chief Development Officer, will ...
(Date:7/1/2015)... PHILADELPHIA , July 1, 2015 ... technology will ... s evidence-based clinical s olutions suite ... scientific, technical and medical information products and services, announced today ... -based clinical decision support (CDS) technology company. InferMed,s ...
(Date:7/1/2015)... NEW YORK , July 1, 2015 /PRNewswire/ ... G ), a global leader in designing, ... the Aecus Innovation Award in recognition of their ... operational efficiencies in UCB,s global business services (GBS) ... acknowledge service providers and clients that work together ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
Breaking Biology Technology:Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... Nov. 30 Binex,(KOSDAQ: 053030) and MaxCyte, Inc. ... to evaluate MaxCyte,s GMP-compliant cell,loading technology for use ... completion of the research studies,the agreement provides Binex ... commercial use in Korea. Financial terms were not ...
... Nov. 30 ABR-Affinity,BioReagents, a leading global antibody manufacturer, ... for Cell Biology,s,47th Annual Meeting in Washington D.C., December ... one of the most significant of the year in ... privileged to participate in,this exciting area of research," said ...
... Kinetics Study Data on ... Monday December 3, 2007, VANCOUVER ... MGIFF), a clinical-stage developer of drugs for infectious,diseases, will host a ... ET (8:00 a.m. PT) to discuss financial results for the,second fiscal ...
Cached Biology Technology:Binex and MaxCyte Collaborate on Cancer Immunotherapy Research 2ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007 2MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification 2
(Date:6/23/2015)... Minn. , June 23, 2015   ... company that supports the entire spectrum of clinical ... iMedNet ™ , the company,s intuitive, ... been awarded a Silver 2015 Stevie® Award by ... Health Products & Services Website category.  The American ...
(Date:6/18/2015)... , June 18, 2015 This report analyzes ... by the following Product Segments, which includes Immunoassay Analyzers ... Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. ... Canada , Japan ... , Latin America , and ...
(Date:6/17/2015)... JOSE, Calif. , June 17, 2015 /PRNewswire/ ... in human interface solutions, today announced that Xiaomi, ... adopted the Synaptics ® ClearPad ® ... of display driver integrated circuits (DDICs) for its ... Pro. By leveraging ClearPad for full in-cell display ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... randomized, placebo-controlled U.S. clinical trial to assess the use ... a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated ... on phase 1 results published in the September issue ... "The use of adult stem cells, derived from the ...
... Wash. Washington State University researchers have discovered the mechanism by ... state. The finding clears the way for a suite of ... brain injuries. "We know that brain activity is linked ... WSU neuroscientist and lead author of a paper in the ...
... (September 14, 2010) -- Because one of the main ... producing good isolated single crystals, improved crystallization techniques would ... pharmaceutical research. Research reported in The ... (FCS) to investigate the processes at the surface of ...
Cached Biology News:First US trial of bone-marrow stem cells for heart attack patients proves safe 2WSU researchers discover key mechanism behind sleep 2How do your crystals grow? 2